INTRODUCING NETRAMARK – A PHARMA AI COMPANY
January 30, 2023
Healthcare Providers & Services
-
-
iCoreConnect Inc. Announces Appointment of Two Leading Industry Executives to Its Board of Directors
January 30, 2023
-
QHSLab, Inc. Reiterates its 2022 Projection of a $7.5 Billion Addressable Market for its Integrated Service Program (ISP) Digital Health Solution Designed For Primary Care
January 30, 2023
-
iCoreConnect Launches a New Software With Concierge Service, iCoreVerify+
January 10, 2023
-
OptimizeRx CEO Issues Open Letter to Shareholders Ahead of Presentation at J.P. Morgan Healthcare Conference
January 4, 2023
-
Healixa Inc. Announces Major Milestone Towards Commercialization of its Global AquaDuct® Product
December 28, 2022
-
Healixa Inc. Appoints Former Pennsylvania Senator Richard Alloway II as Executive Vice President for Government Relations
December 20, 2022
-
iCoreConnect Earns the Endorsement of The PROPS Center, a Subsidiary of The Connecticut State Dental Association
December 7, 2022
-
NUROSENE CHIEF SCIENCE OFFICER PRESENTS AT LEADING DRUG DEVELOPMENT FORUM
December 6, 2022
-
Healixa Inc. Appoints Former Acting Secretary of Defense of The United States Christopher C. Miller to Its Advisory Board
December 1, 2022
-
VDA Member Perks Adds Five More iCoreConnect Product Endorsements
December 1, 2022
-
Healixa Expands Advisory Board with Appointment of Accomplished C-Level Executive with History of Accelerating Profitable Growth
November 29, 2022
-
HippoFi’s Regenerative Therapeutics Division, Launches PURbridge(TM) for Spine Surgery
November 23, 2022
-
QHSLab, Inc. Projects a $7.5 Billion Addressable Market for its Integrated Service Program (ISP) Digital Health Solution Designed For Primary Care
November 14, 2022
-
Healixa Health Care Signs Initial Revenue Contracts
November 10, 2022
-
Healixa Inc Retains Investment Bank Firm Craft Capital Management LLC to Provide Investment Banking and Up-Listing Advisory Services
November 3, 2022